1ICY
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 1icy by Molmil](/molmil-images/mine/1icy) | [ALA31,PRO32]-PNPY BOUND TO DPC MICELLES | Descriptor: | NEUROPEPTIDE Y | Authors: | Bader, R, Rytz, G, Lerch, M, Beck-Sickinger, A.G, Zerbe, O. | Deposit date: | 2001-04-02 | Release date: | 2002-05-08 | Last modified: | 2021-10-27 | Method: | SOLUTION NMR | Cite: | Key motif to gain selectivity at the neuropeptide Y5-receptor: structure and dynamics of micelle-bound [Ala31, Pro32]-NPY. Biochemistry, 41, 2002
|
|
1F8P
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 1f8p by Molmil](/molmil-images/mine/1f8p) | |
1FVN
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 1fvn by Molmil](/molmil-images/mine/1fvn) | |
2RLK
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 2rlk by Molmil](/molmil-images/mine/2rlk) | Refined solution structure of porcine peptide YY (PYY) | Descriptor: | Peptide YY | Authors: | Neumoin, A, Mares, J, Lerch-Bader, M, Bader, R, Zerbe, O. | Deposit date: | 2007-07-21 | Release date: | 2007-08-14 | Last modified: | 2022-03-16 | Method: | SOLUTION NMR | Cite: | Probing the formation of stable tertiary structure in a model miniprotein at atomic resolution: determinants of stability of a helical hairpin J.Am.Chem.Soc., 129, 2007
|
|
1LJV
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 1ljv by Molmil](/molmil-images/mine/1ljv) | Bovine Pancreatic Polypeptide Bound to DPC Micelles | Descriptor: | PANCREATIC HORMONE | Authors: | Lerch, M, Gafner, V, Bader, R, Christen, B, Zerbe, O. | Deposit date: | 2002-04-22 | Release date: | 2002-10-09 | Last modified: | 2022-02-23 | Method: | SOLUTION NMR | Cite: | Bovine pancreatic polypeptide (bPP) undergoes significant changes in conformation and dynamics upon binding to DPC micelles. J.Mol.Biol., 322, 2002
|
|
2KLE
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 2kle by Molmil](/molmil-images/mine/2kle) | |
2KLD
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 2kld by Molmil](/molmil-images/mine/2kld) | |
2OOP
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 2oop by Molmil](/molmil-images/mine/2oop) | Structure of Tyr7-PYY in solution | Descriptor: | Peptide YY | Authors: | Zerbe, O, Neumoin, A, Mares, J. | Deposit date: | 2007-01-26 | Release date: | 2007-12-25 | Last modified: | 2023-12-27 | Method: | SOLUTION NMR | Cite: | Probing the formation of stable tertiary structure in a model miniprotein at atomic resolution: determinants of stability of a helical hairpin. J.Am.Chem.Soc., 129, 2007
|
|
2OON
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 2oon by Molmil](/molmil-images/mine/2oon) | Structure of Ala14-PYY in aqueous solution | Descriptor: | Peptide YY | Authors: | Zerbe, O, Neumoin, A, Mares, J. | Deposit date: | 2007-01-26 | Release date: | 2007-12-25 | Last modified: | 2023-12-27 | Method: | SOLUTION NMR | Cite: | Probing the formation of stable tertiary structure in a model miniprotein at atomic resolution: determinants of stability of a helical hairpin. J.Am.Chem.Soc., 129, 2007
|
|
7YXU
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 7yxu by Molmil](/molmil-images/mine/7yxu) | Crystal structure of agonistic antibody 1618 fab domain bound to human 4-1BB. | Descriptor: | MANGANESE (II) ION, Tumor necrosis factor receptor superfamily member 9, heavy chain of Fab, ... | Authors: | Hakansson, M, Rose, N, Petersson, J, Enell Smith, K, Thorolfsson, M, von Schantz, L. | Deposit date: | 2022-02-16 | Release date: | 2023-01-25 | Last modified: | 2024-02-07 | Method: | X-RAY DIFFRACTION (2.31 Å) | Cite: | The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies. Mol.Cancer Ther., 22, 2023
|
|